Vanguard Group Inc. Sells 20,228 Shares of Perrigo Company plc (NYSE:PRGO)

Vanguard Group Inc. reduced its holdings in Perrigo Company plc (NYSE:PRGO) by 0.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,872,960 shares of the company’s stock after selling 20,228 shares during the quarter. Vanguard Group Inc. owned 10.90% of Perrigo worth $382,384,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Versant Capital Management Inc bought a new position in shares of Perrigo in the fourth quarter worth approximately $45,000. GAMMA Investing LLC increased its holdings in shares of Perrigo by 93.7% in the 4th quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock worth $49,000 after buying an additional 929 shares during the last quarter. Central Pacific Bank Trust Division raised its position in shares of Perrigo by 33.3% during the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after buying an additional 500 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in shares of Perrigo by 97.8% during the 4th quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company’s stock worth $108,000 after acquiring an additional 2,084 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in Perrigo in the fourth quarter worth $149,000. Hedge funds and other institutional investors own 95.91% of the company’s stock.

Insider Buying and Selling

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the business’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the transaction, the executive vice president now directly owns 33,666 shares of the company’s stock, valued at approximately $923,795.04. The trade was a 18.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.70% of the stock is owned by insiders.

Perrigo Trading Up 0.8 %

Shares of PRGO stock opened at $27.91 on Thursday. The business has a 50-day moving average of $26.34 and a 200 day moving average of $26.17. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. Perrigo Company plc has a 1-year low of $23.14 and a 1-year high of $33.46. The stock has a market capitalization of $3.81 billion, a PE ratio of -23.85 and a beta of 0.48.

Perrigo (NYSE:PRGO) last issued its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.20 billion. As a group, sell-side analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 4.16%. This is an increase from Perrigo’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, March 7th. Perrigo’s dividend payout ratio is -92.80%.

Analyst Upgrades and Downgrades

PRGO has been the subject of several research analyst reports. StockNews.com lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Finally, Piper Sandler downgraded shares of Perrigo from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $34.00 to $27.00 in a research note on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $33.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.